Analyst Ranking
Bottom 4%
#4738 out of 4906 analysts
Average Return
-12.27%
Win Rate
34%25 out of 73
Risk vs Reward
Poor
Good

Leonid Timashev's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Newamsterdam Pharma Co NvNAMS
+164.57%$7.17$18.97
2023-10-30 -
2024-10-29
Buy
Edgewise Therapeutics IncEWTX
+131.48%$7.56$17.50
2023-06-28 -
2024-06-27
Buy
Axsome Therapeutics IncAXSM
+57.23%$82.11$129.10
2024-02-21 -
2025-02-20
Buy
Axsome Therapeutics IncAXSM
+56.88%$76.72$120.36
2024-03-26 -
2025-03-25
Buy
Pyxis Oncology IncPYXS
+56.70%$2.24$3.51
2023-09-05 -
2024-09-04
Buy

Leonid Timashev Analyst Color

Get additional color on Leonid Timashev's coverage of popular stocks

Leonid Timashev's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Axsome Therapeutics IncAXSM
11Buy$186.00+78.67%Maintains
4 days ago
Insmed IncINSM
3Buy$106.00+7.36%Maintains
5 days ago
Edgewise Therapeutics IncEWTX
12Buy$48.00+213.93%Reiterates
11 days ago
Perspective Therapeutics IncCATX
1Buy$16.00+404.73%Maintains
13 days ago
Biohaven LtdBHVN
12Hold$21.00+35.83%Downgrades
a month ago
Cytokinetics IncCYTK
3Buy$80.00+132.69%Maintains
a month ago
Alkermes PLCALKS
2Hold$40.00+34.09%Maintains
a month ago
Pyxis Oncology IncPYXS
6Buy$8.00+566.67%Reiterates
3 months ago
Brc IncBRCC
1Strong Buy$3.00+100.00%Maintains
3 months ago
Newamsterdam Pharma Co NvNAMS
6Buy$40.00+97.92%Reiterates
5 months ago
Incyte CorpINCY
1Hold$70.00+3.32%Reiterates
5 months ago
Compass Pathways PLCCMPS
4Buy$18.00+310.02%Reiterates
5 months ago
Legend Biotech CorpLEGN
11Buy$86.00+133.51%Reiterates
6 months ago
Design Therapeutics IncDSGN
8Hold$4.00+4.17%Reiterates
10 months ago
Neubase Therapeutics IncNBSE
1Hold$20.00N/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.